1 Bonifacino, J. S. and Glick, B. S. (2004) The mechanisms of vesicle budding and fusion.
Cell 116, 153–166
2 Schekman, R. and Novick, P. (2004) 23 genes, 23 years later. Cell 116, S13–S15
3 Donaldson, J. G., Lippincott-Schwartz, J., Bloom, G. S., Kreis, T. E. and Klausner, R. D.
(1990) Dissociation of a 110-kD peripheral membrane protein from the Golgi apparatus
is an early event in brefeldin A action. J. Cell Biol. 111, 2295–2306
4 Orci, L., Tagaya, M., Amherdt, M., Perrelet, A., Donaldson, J. G., Lippincott-Schwartz, J.,
Klausner, R. D. and Rothman, J. E. (1991) Brefeldin A, a drug that blocks secretion,
prevents the assembly of non-clathrin-coated buds on Golgi cisternae. Cell 64,
1183–1195
5 Lippincott-Schwartz, J., Yuan, L. C., Bonifacino, J. S. and Klausner, R. D. (1989) Rapid
redistribution of Golgi proteins into the ER in cells treated with brefeldin A: evidence for
membrane cycling from Golgi to ER. Cell 56, 801–813
6 Scheel, J., Pepperkok, R., Lowe, M., Griffiths, G. and Kreis, T. E. (1997) Dissociation of
coatomer from membranes is required for brefeldin A-induced transfer of Golgi enzymes
to the endoplasmic reticulum. J. Cell Biol. 137, 319–333
7 Lippincott-Schwartz, J., Yuan, L., Tipper, C., Amherdt, M., Orci, L. and Klausner, R. D.
(1991) Brefeldin A’s effects on endosomes, lysosomes, and the TGN suggest a general
mechanism for regulating organelle structure and membrane traffic. Cell 67,
601–616
8 Wood, S. A., Park, J. E. and Brown, W. J. (1991) Brefeldin A causes a
microtubule-mediated fusion of the trans-Golgi network and early endosomes. Cell 67,
591–600
9 Reaves, B. and Banting, G. (1992) Perturbation of the morphology of the trans-Golgi
network following Brefeldin A treatment: redistribution of a TGN-specific integral
membrane protein, TGN38. J. Cell Biol. 116, 85–94
10 Helms, J. B. and Rothman, J. E. (1992) Inhibition by brefeldin A of a Golgi membrane
enzyme that catalyses exchange of guanine nucleotide bound to ARF. Nature 360,
352–354
11 Jones, H. D., Moss, J. and Vaughan, M. (2005) BIG1 and BIG2, brefeldin A-inhibited
guanine nucleotide-exchange factors for ADP-ribosylation factors. Methods Enzymol.
404, 174–184
12 Zeghouf, M., Guibert, B., Zeeh, J. C. and Cherfils, J. (2005) Arf, Sec7 and Brefeldin A:
a model towards the therapeutic inhibition of guanine nucleotide-exchange factors.
Biochem. Soc. Trans. 33, 1265–1268
13 Robineau, S., Chabre, M. and Antonny, B. (2000) Binding site of brefeldin A at the
interface between the small G protein ADP-ribosylation factor 1 (ARF1) and the
nucleotide-exchange factor Sec7 domain. Proc. Natl. Acad. Sci. U.S.A. 97,
9913–9918
14 Peyroche, A., Antonny, B., Robineau, S., Acker, J., Cherfils, J. and Jackson, C. L. (1999)
Brefeldin A acts to stabilize an abortive ARF-GDP-Sec7 domain protein complex:
involvement of specific residues of the Sec7 domain. Mol. Cell 3, 275–285
15 Zeeh, J. C., Zeghouf, M., Grauffel, C., Guibert, B., Martin, E., Dejaegere, A. and
Cherfils, J. (2006) Dual specificity of the interfacial inhibitor brefeldin a for arf proteins
and sec7 domains. J. Biol. Chem. 281, 11805–11814
16 Mossessova, E., Corpina, R. A. and Goldberg, J. (2003) Crystal structure of ARF1*Sec7
complexed with Brefeldin A and its implications for the guanine nucleotide exchange
mechanism. Mol. Cell 12, 1403–1411
17 Feng, Y., Yu, S., Lasell, T. K., Jadhav, A. P., Macia, E., Chardin, P., Melancon, P., Roth,
M., Mitchison, T. and Kirchhausen, T. (2003) Exo1: a new chemical inhibitor of the
exocytic pathway. Proc. Natl. Acad. Sci. U.S.A. 100, 6469–6474
18 Feng, Y., Jadhav, A. P., Rodighiero, C., Fujinaga, Y., Kirchhausen, T. and Lencer, W. I.
(2004) Retrograde transport of cholera toxin from the plasma membrane to the
endoplasmic reticulum requires the trans-Golgi network but not the Golgi apparatus in
Exo2-treated cells. EMBO Rep. 5, 596–601
19 Spooner, R. A., Watson, P. D., Marsden, C. J., Smith, D. C., Moore, K. A., Cook, J. P.,
Lord, J. M. and Roberts, L. M. (2004) Protein disulphide-isomerase reduces
ricin to its A and B chains in the endoplasmic reticulum. Biochem. J. 383,
285–293
20 Aghi, M., Kramm, C. M., Chou, T. C., Breakefield, X. O. and Chiocca, E. A. (1998)
Synergistic anticancer effects of ganciclovir/thymidine kinase and
5-fluorocytosine/cytosine deaminase gene therapies. J. Natl. Cancer Inst. 90,
370–380
20a Stephens, D. J. (2003) De novo formation, fusion and fission of COPII coated ER exit
sites in mammalian cells. EMBO Rep. 4, 210–217
21 Watson, P., Townley, A. K., Koka, P., Palmer, K. J. and Stephens, D. J. (2006) Sec16
defines endoplasmic reticulum exit sites and is required for secretory cargo export in
mammalian cells. Traffic 7, 1678–1687
22 Johannes, L., Tenza, D., Antony, C. and Goud, B. (1997) Retrograde transport of
KDEL-bearing B-fragment of Shiga toxin. J. Biol. Chem. 272, 19554–19561
23 Falguieres, T., Mallard, F., Baron, C., Hanau, D., Lingwood, C., Goud, B., Salamero, J.
and Johannes, L. (2001) Targeting of Shiga toxin B-subunit to retrograde transport
route in association with detergent-resistant membranes. Mol. Biol. Cell 12,
2453–2468
24 Fujinaga, Y., Wolf, A. A., Rodighiero, C., Wheeler, H., Tsai, B., Allen, L., Jobling, M. G.,
Rapoport, T., Holmes, R. K. and Lencer, W. I. (2003) Gangliosides that associate with
lipid rafts mediate transport of cholera and related toxins from the plasma membrane to
endoplasmic reticulm. Mol. Biol. Cell 14, 4783–4793
25 Girod, A., Storrie, B., Simpson, J. C., Johannes, L., Goud, B., Roberts, L. M., Lord,
J. M., Nilsson, T. and Pepperkok, R. (1999) Evidence for a COP-I-independent transport
route from the Golgi complex to the endoplasmic reticulum. Nat. Cell Biol. 1,
423–430
26 Smith, D. C., Sillence, D. J., Falguieres, T., Jarvis, R. M., Johannes, L., Lord, J. M.,
Platt, F. M. and Roberts, L. M. (2006) The association of Shiga-like toxin with detergentresistant
membranes is modulated by glucosylceramide and is an essential
requirement in the endoplasmic reticulum for a cytotoxic effect. Mol. Biol. Cell 17,
1375–1387
27 Hallas, G. and Towns, A. D. (1996) A comparison of the properties of some
2-aminothiophene-derived disperse dyes. Dyes and Pigments 31, 273–289
28 Joseph, P. S., Selladurai, S., Kanna, S. and Parthasarathi, V. (1990) Structure of
4-oxo-5,6,7,8-tetrahydro-3H-cyclohexathieno[2,3-d]pyrimidine. Acta Crystallogr. C 46,
162–163
29 Ram, V. J., Pandey, H. K. and Vlietinck, A. J. (1981) Thieno[2,3-d]pyrimidines as
potential chemotherapeutic agents. II. J. Heterocyclic Chem. 18, 1277–1280
30 Shvedov, V. I., Ryzhkova, V. K. and Grinev, A. N. (1967) Synthesis of
4-hydroxythieno[2,3-d]pyrimidine derivatives. Khim. Geterotsikl. Soedin. 3,
459–460
31 Ram, V. J. (1979) Thieno[2,3-d]pyrimidines as potential chemotherapeutic agents.
Arch. Pharm. (Weinheim) 312, 19–25
32 Robba, M. and Maume, D. (1972) Conditions of access to as-triazino(4,5-a)indole.
Tetrahedron Lett. 13, 2333–2335
33 Endo, Y., Tsurugi, K., Yutsudo, T., Takeda, Y., Ogasawara, T. and Igarashi, K. (1988) Site
of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on
eukaryotic ribosomes. RNA N-glycosidase activity of the toxins. Eur. J. Biochem. 171,
45–50
34 Garred, O., van Deurs, B. and Sandvig, K. (1995) Furin-induced cleavage and activation
of Shiga toxin. J. Biol. Chem. 270, 10817–10821
35 Kovbasnjuk, O., Mourtazina, R., Baibakov, B., Wang, T., Elowsky, C., Choti, M. A.,
Kane, A. and Donowitz, M. (2005) The glycosphingolipid globotriaosylceramide in the
metastatic transformation of colon cancer. Proc. Natl. Acad. Sci. U.S.A. 102,
19087–19092
36 Sandvig, K., Ryd, M., Garred, O., Schweda, E., Holm, P. K. and van Deurs, B. (1994)
Retrograde transport from the Golgi complex to the ER of both Shiga toxin and the
nontoxic Shiga B-fragment is regulated by butyric acid and cAMP. J. Cell Biol. 126,
53–64
37 Sandvig, K., Prydz, K., Ryd, M. and van Deurs, B. (1991) Endocytosis and intracellular
transport of the glycolipid-binding ligand Shiga toxin in polarized MDCK cells.
J. Cell Biol. 113, 553–562
38 Gallione, C. J. and Rose, J. K. (1985) A single amino acid substitution in a hydrophobic
domain causes temperature-sensitive cell-surface transport of a mutant viral
glycoprotein. J. Virol. 54, 374–382
39 Presley, J. F., Cole, N. B., Schroer, T. A., Hirschberg, K., Zaal, K. J. and
Lippincott-Schwartz, J. (1997) ER-to-Golgi transport visualized in living cells. Nature
389, 81–85
40 Shima, D. T., Haldar, K., Pepperkok, R., Watson, R. and Warren, G. (1997) Partitioning
of the Golgi apparatus during mitosis in living HeLa cells. J. Cell Biol. 137,
1211–1228
41 Reaves, B., Horn, M. and Banting, G. (1993) TGN38/41 recycles between the cell
surface and the TGN: brefeldin A affects its rate of return to the TGN. Mol. Biol. Cell 4,
93–105
42 Lee, R. W. and Huttner, W. B. (1983) Tyrosine-O-sulfated proteins of PC12
pheochromocytoma cells and their sulfation by a tyrosylprotein sulfotransferase.
J. Biol. Chem. 258, 11326–11334
43 Baeuerle, P. A. and Huttner, W. B. (1987) Tyrosine sulfation is a trans-Golgi-specific
protein modification. J. Cell Biol. 105, , 2655–2664
44 Huttner, W. B. (1988) Tyrosine sulfation and the secretory pathway. Annu. Rev. Physiol.
50, 363–376
45 Beisswanger, R., Corbeil, D., Vannier, C., Thiele, C., Dohrmann, U., Kellner, R.,
Ashman, K., Niehrs, C. and Huttner, W. B. (1998) Existence of distinct tyrosylprotein
sulfotransferase genes: molecular characterization of tyrosylprotein sulfotransferase-2.
Proc. Natl. Acad. Sci. U.S.A. 95, 11134–11139
46 Ouyang, Y., Lane, W. S. and Moore, K. L. (1998) Tyrosylprotein sulfotransferase:
purification and molecular cloning of an enzyme that catalyzes tyrosine O-sulfation,
a common posttranslational modification of eukaryotic proteins. Proc. Natl. Acad.
Sci. U.S.A. 95, 2896–2901
47 Ponnambalam, S., Girotti, M., Yaspo, M. L., Owen, C. E., Perry, A. C., Suganuma, T.,
Nilsson, T., Fried, M., Banting, G. and Warren, G. (1996) Primate homologues of rat
TGN38: primary structure, expression and functional implications. J. Cell Sci. 109,
675–685
48 Prescott, A. R., Lucocq, J. M., James, J., Lister, J. M. and Ponnambalam, S. (1997)
Distinct compartmentalization of TGN46 and β1,4-galactosyltransferase in HeLa cells.
Eur. J. Cell Biol. 72, 238–246
49 Thyberg, J. and Moskalewski, S. (1985) Microtubules and the organization of the Golgi
complex. Exp. Cell Res. 159, 1–16
50 White, J., Johannes, L., Mallard, F., Girod, A., Grill, S., Reinsch, S., Keller, P.,
Tzschaschel, B., Echard, A., Goud, B. and Stelzer, E. H. (1999) Rab6 coordinates
a novel Golgi to ER retrograde transport pathway in live cells. J. Cell. Biol. 147,
743–760
51 Fjeldstad, K., Pedersen, M. E., Vuong, T. T., Kolset, S. O., Nordstrand, L. M. and
Prydz, K. (2002) Sulfation in the Golgi lumen of Madin-Darby canine kidney cells is
inhibited by brefeldin A and depends on a factor present in the cytoplasm and
on Golgi membranes. J. Biol. Chem. 277, 36272–36279
52 Muller, L., Barret, A., Picart, R. and Tougard, C. (1997) Proteolytic processing of sulfated
secretogranin II in the trans-Golgi network of GH3B6 prolactin cells. J. Biol. Chem. 272,
3669–3673
53 Nichols, B. J., Kenworthy, A. K., Polishchuk, R. S., Lodge, R., Roberts, T. H.,
Hirschberg, K., Phair, R. D. and Lippincott-Schwartz, J. (2001) Rapid cycling of
lipid raft markers between the cell surface and Golgi complex. J. Cell Biol.
153, 529–541